- Home
- /
- Treatment
- /
- Page 143
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Interleukin-3 human (recombinant) | Anemia- Hypoplastic- Congenital | Immunex Corporation;51 University Street;Seattle, Washington, 98101 | May 20, 1991 | |
Poly I: poly C12U | Renal cancer | Hemispherx Biopharma, Inc.;1617 JFK Boulvard, Suite 500;Philadelphia, Pennsylvania, 19103 | May 20, 1991 | |
Interferon beta (recombinant) | For the intralesional and/or systemic treatment of AIDS-related Kaposi's sarcoma | Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142 | May 9, 1991 | |
Histrelin | Acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria | Anderson, Karl E., M.D.;University of Texas Medical Branch at Galveston, Route J-09, 700 The Strand;Galveston, Texas, 77550 | May 3, 1991 | |
Thymalfasin | Chronic active hepatitis B | SciClone Pharmaceuticals, Inc.;950 Tower Lane, Suite 900;Foster City, California, 94404 | May 3, 1991 | |
Etidronate disodium | Prevention of degenerative metabolic bone disease occurring in patients who require long term (6 months or greater) total parenteral nutrition | MGI Pharma, Inc.;6300 West Old Shakoppe Rd., Suite 110;Bloomington, Minnesota, 55438 | May 2, 1991 | |
Etidronate disodium | Degenerative metabolic bone disease occurring in patients who require long term (6 months or greater) total parenteral nutrition | MGI Pharma, Inc.;6300 West Old Shakoppe Rd., Suite 110;Bloomington, Minnesota, 55438 | May 2, 1991 | |
Interferon beta (recombinant) | For the systemic treatment of cutaneous T-cell lymphoma | Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142 | April 18, 1991 | |
Recombinant human superoxide dismutase | Bronchopulmonary dysplasia | Savient Pharmaceuticals, Inc.;One Tower Center Boulevard, 12th floor;East Brunswick, New Jersey, 08816 | April 18, 1991 | |
Ofloxacin | Bacterial corneal ulcers | Allergan, Inc.;2525 Dupont Drive, P.O. Box 19534;Irvine, California, 92713 | April 18, 1991 | |
Interferon beta-1a (recombinant) | For the systemic treatment of cutaneous malignant melanoma | Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142 | April 3, 1991 | |
Recombinant secretory leucocyte protease inhibitor | Congenital alpha-1 antitrypsin deficiency | Amgen Inc.;3200 Walnut Street;Boulder, Colorado, 80301 | March 29, 1991 | |
Recombinant secretory leucocyte protease inhibitor | Cystic fibrosis | Amgen, Inc.;3200 Walnut Street;Boulder, Colorado, 80301 | March 29, 1991 | |
Ketoconazole | For use with cyclosporine A to diminish the nephrotoxicity induced by cyclosporine in organ transplantation | Pharmedic Company;28101 Ballard Road;Lake Forest, Illinois, 60045 | March 27, 1991 | |
Succimer | Mercury intoxication | Sanofi Winthrop, Inc.;90 Park Avenue;New York, New York, 10016 | March 22, 1991 | |
Poloxamer 331 | Initial therapy of toxoplasmosis in patients with AIDS | CytRx Corporation;154 Technology Parkway;Norcross, Georgia, 30092 | March 21, 1991 | |
Dextran and deferoxamine | Acute iron poisoning | Biomedical Frontiers, Inc.;1095 10th Avenue S.E.;Minneapolis, Minnesota, 55414 | March 8, 1991 | |
Sucralfate suspension | Oral ulcerations and dysphagia in patients with epidermolysis bullosa | Darby Pharmaceuticals, Inc.;100 Banks Avenue;Rockville Centre, New York, 11570 | March 4, 1991 | |
Ursodiol | Primary biliary cirrhosis | Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936 | February 19, 1991 | |
Interferon beta (recombinant) | For the systemic treatment of metastatic renal cell carcinoma | Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142 | February 12, 1991 | |
Idarubicin HCl for injection | Acute lymphoblastic leukemia | Pfizer, Inc.;235 East 42nd Street;New York, New York, 10017 | February 12, 1991 | |
Antivenom (crotalidae) purified (avian) | Envenomation by poisonous snakes belonging to the Crotalidae family | Ophidian Pharmaceuticals, Inc.;5445 East Cheryl Parkway;Madison, Wisconsin, 53711 | February 12, 1991 | |
Gentamicin impregnated PMMA beads on surgical wire | Osteomyelitis | Lipha Pharmaceuticals, Inc.;9 West 57th Street, Suite 3825;New York, New York, 10019 | January 31, 1991 | |
Pentostatin | Chronic lymphocytic leukemia | SuperGen, Inc.;Two Annabel Lane, Suite 220;San Ramon, California, 94583 | January 29, 1991 | |
Cytomegalovirus immune globulin intravenous (human) | For use in conjunction with ganciclovir sodium for the treatment of cytomegalovirus pneumonia in bone marrow transplant patients | Bayer Corporation;Pharmaceutical Division, Biological Products, 400 Morgan Lane;New Haven, Connecticut, 06516 | January 28, 1991 |